Skip to main content

Novo Nordisk showers at least $25.8M on U.S. obesity doctors, Reuters says

By Reuters  
   December 06, 2023

Novo Nordisk paid clinicians at least $25.8 million over a decade in fees and expenses related to its weight-loss drugs, concentrating that money on an elite group of obesity specialists.

Full story

Get the latest on healthcare leadership in your inbox.